Yu-jia H. Chang

250 Wu Xin Street, 110
Taipei, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Homer3 Promotes Aggressive Phenotypes in Triple-Negative Breast Cancer Through Cell Cycle- and MYC-Associated Programs.

Homer3 Promotes Aggressive Phenotypes in Triple-Negative Breast Cancer Through Cell Cycle- and MYC-Associated Programs.

Journal: International journal of molecular sciences

Published: May 12, 2026

ALDH2 regulates oxaliplatin sensitivity via PDE4B in p53-mutant colorectal cancer.

ALDH2 regulates oxaliplatin sensitivity via PDE4B in p53-mutant colorectal cancer.

Journal: International journal of medical sciences

Published: February 24, 2026

M2 macrophage infiltration associated with CXCL8 predicts grade 4 prognosis and differentiates glioma grades.

M2 macrophage infiltration associated with CXCL8 predicts grade 4 prognosis and differentiates glioma grades.

Journal: Discover oncology

Published: June 27, 2025

Solute Carrier Family 35 A2 (SLC35A2) Promotes Tumor Progression through MYC-Mediated Pathways in Colorectal Cancer.

Solute Carrier Family 35 A2 (SLC35A2) Promotes Tumor Progression through MYC-Mediated Pathways in Colorectal Cancer.

Journal: International journal of medical sciences

Published: January 02, 2025

Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.

Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.

Journal: Journal of clinical medicine

Published: October 05, 2023

The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression.

The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression.

Journal: Cell biology international

Published: September 05, 2023

CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

Journal: International journal of molecular sciences

Published: September 04, 2023

2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.

2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.

Journal: Biomedicines

Published: May 29, 2023

Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma

Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 15, 2023

PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.

PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.

Journal: International journal of molecular sciences

Published: May 12, 2023

Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer.

Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer.

Journal: Journal of translational medicine

Published: May 10, 2023

Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Journal: International journal of molecular sciences

Published: April 21, 2023

Showing 1-12 of 102

Last Updated: 09/26/2026